13D Filing: James E. Flynn and Adeptus Health Inc. (ADPT)

Page 3 of 11 – SEC Filing

 SCHEDULE 13D

CUSIP No.  006855100 Page 3 of 8 Pages
1

NAME OF REPORTING PERSONS

Deerfield Management Company, L.P.

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐

(b) ☒

3

SEC USE ONLY

4

SOURCE OF FUNDS

AF

5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)

6

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

 

 

 NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

7

SOLE VOTING POWER

0

8

SHARED VOTING POWER

798,297 (2)

9

SOLE DISPOSITIVE POWER

0

10

SHARED DISPOSITIVE POWER

798,297 (2)

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

798,297 (2)

12

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES*

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

4.87% (2)

14

TYPE OF REPORTING PERSON

PN

(2) Consists of shares of Class A Common Stock held by Deerfield Partners, L.P. and Deerfield International
Master Fund, L.P., of each of which Deerfield Management Company, L.P. is the investment adviser. The percentage of outstanding
Class A Common Stock beneficially owned has been determined based on 16,395,599 shares of Class A Common Stock outstanding as
of November 7, 2016, as set forth in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September
30, 2016.

Follow Adeptus Health Inc. (NYSE:ADPT)